Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you employ a phrenic nerve dose constraint with conventional fractionation?
E.g. breast or H&N cancers when boosting the supraclav area.
Answer from: Radiation Oncologist at Community Practice
No.
Sign in or Register to read more
14494
Related Questions
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
How would you best manage C-spine osteoradionecrosis?
When would you consider larynx preservation in patients with T4N+ SCC of the larynx?
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
What is the recommended adjuvant dose for neuroendocrine cancer in the head and neck?
How would you approach cT3N0M0 squamous cell carcinoma of the supraglottic larynx in a patient with a history of breast cancer and prior radiation to the supraclavicular fossa?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
Are there any special treatment considerations when treating a patient with laryngeal cancer with significant Reinke's edema of the vocal folds?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?